Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression.
Stanzione R, Picascia A, Chieffi P, Imbimbo C, Palmieri A, Mirone V, Staibano S, Franco R, De Rosa G, Schlessinger J, Tramontano D.
Stanzione R, et al. Among authors: imbimbo c.
Lab Invest. 2001 Jan;81(1):51-9. doi: 10.1038/labinvest.3780211.
Lab Invest. 2001.
PMID: 11204274
Free article.